Press Releases: 2018

HLS THERAPEUTICS COMPLETES MERGER WITH AUTOMODULAR CORPORATION

HLS Expected to Begin Trading on the TSXV on March 14, 2018

TORONTO, ONTARIO – March 12, 2018 – HLS Therapeutics Inc. (“HLS”) today announced the completion of the amalgamation of former HLS Therapeutics Inc. and Automodular Corporation (“AMD”) to form an amalgamated Ontario corporation to be known as “HLS Therapeutics Inc.” pursuant to a plan of arrangement (the “Arrangement”) under section 182 of the Business Corporations Act (Ontario). The Arrangement constitutes a Reverse Takeover of AMD pursuant to Policy 5.2 of the TSX Venture Exchange (the “TSXV”).

See full press release here.